BIONOMICS LTD-ADR (BNOX) Stock Price, Quote, News and Overview
NASDAQ:BNOX - Nasdaq - US09063M2052 - ADR - Currency: USD
BNOX Quote, Performance and Key Statistics
0.2531
+0.01 (+4.2%)
The current stock price of BNOX is 0.2531 USD. In the past month the price decreased by -14.09%. In the past year, price decreased by -82.9%.
BNOX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About BNOX
Company Profile
Bionomics Ltd is a AU-based company operating in Biotechnology industry. Bionomics Ltd is an Australia-based clinical-stage biopharmaceutical company. The firm is focused on development of novel drug candidates focused on the treatment of serious central nervous system disorders. The company is developing novel allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need. The company is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the α7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder (SAD) and chronic treatment of post-traumatic stress disorder (PTSD). Its α7 Receptor Positive Allosteric Modulators (PAMs) pipeline is targeting cognitive dysfunction associated with Alzheimer’s disease and other central nervous system conditions. The Company’s CNS pipeline also includes preclinical assets that target Kv3.1/3.2 and Nav1.7/1.8 ion channels.
Company Info
BIONOMICS LTD-ADR
200 Greenhill Road
Thebarton SOUTH AUSTRALIA AU
Employees: 8
Company Website: https://www.bionomics.com.au/
Investor Relations: https://www.bionomics.com.au/investor-centre/
Phone: 61881507400
BIONOMICS LTD-ADR / BNOX FAQ
What is the stock price of BIONOMICS LTD-ADR today?
The current stock price of BNOX is 0.2531 USD. The price increased by 4.2% in the last trading session.
What is the ticker symbol for BIONOMICS LTD-ADR stock?
The exchange symbol of BIONOMICS LTD-ADR is BNOX and it is listed on the Nasdaq exchange.
On which exchange is BNOX stock listed?
BNOX stock is listed on the Nasdaq exchange.
What is BIONOMICS LTD-ADR worth?
BIONOMICS LTD-ADR (BNOX) has a market capitalization of 4.94M USD. This makes BNOX a Nano Cap stock.
How many employees does BIONOMICS LTD-ADR have?
BIONOMICS LTD-ADR (BNOX) currently has 8 employees.
What are the support and resistance levels for BIONOMICS LTD-ADR (BNOX) stock?
BIONOMICS LTD-ADR (BNOX) has a resistance level at 0.29. Check the full technical report for a detailed analysis of BNOX support and resistance levels.
Is BIONOMICS LTD-ADR (BNOX) expected to grow?
The Revenue of BIONOMICS LTD-ADR (BNOX) is expected to decline by -80.75% in the next year. Check the estimates tab for more information on the BNOX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIONOMICS LTD-ADR (BNOX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BNOX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BNOX, evaluating the profitability, health, valuation and growth aspects
- BIONOMICS LTD-ADR (BNOX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIONOMICS LTD-ADR (BNOX) Sales and EPS estimates to see what analysts future expectations are.
- BIONOMICS LTD-ADR (BNOX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIONOMICS LTD-ADR (BNOX) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIONOMICS LTD-ADR (BNOX) Stock Chart to make your own analysis
- BIONOMICS LTD-ADR (BNOX) Latest news and press-releases to stay up to date.
Does BIONOMICS LTD-ADR (BNOX) stock pay dividends?
BNOX does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIONOMICS LTD-ADR (BNOX)?
BIONOMICS LTD-ADR (BNOX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.12).
BNOX Technical Analysis
BNOX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNOX. BNOX may be in some trouble as it scores bad on both profitability and health.
BNOX Financial Highlights
Over the last trailing twelve months BNOX reported a non-GAAP Earnings per Share(EPS) of -3.12. The EPS decreased by -115.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -131.15% | ||
| ROE | -175.51% | ||
| Debt/Equity | 0.05 |
BNOX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to BNOX. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 33.83% and a revenue growth -80.75% for BNOX